* Tata Motors: The company reported a 222% surge in net profit to ₹17,407.2 crore in Q4FY24, driven by strong performance across all auto businesses. The company's total revenue rose 14.3% to ₹1.2 lakh crore. The board recommended a final dividend of ₹6 per ordinary share and ₹6.20 per ‘A’ ordinary share for FY24.
* ICICI Bank: Bijith Bhaskar, the Head of Cards, Payment Solutions, E-Commerce Ecosystem, Merchant Ecosystem, and Consumer Finance, has resigned from his position, effective May 18.
* Vedanta: The company's unit, CIHL, acquired an additional 46.57% stake in Avanstrate for JPY 12.2 billion.
* Wipro: Anis Chenchah, head of Asia Pacific, the Middle East, and Africa at Wipro Ltd, has resigned. His resignation comes amid challenging times for Wipro's APMEA business.
* Eicher Motors: The company reported an 18.2% rise in consolidated net profit to ₹1,070.45 crore in Q4FY24. The company’s total revenue increased 11.87% to ₹4,256.04 crore. The board recommended a final dividend of ₹51 per equity share for FY24.
* Adani Enterprises: The Gautam Adani-led company plans to invest ₹80,000 crore in FY25, with a significant portion going towards new energy businesses and airports. The company also aims to produce 10 GW solar modules and 3 GW wind turbines.
* ICICI Bank: Bijith Bhaskar, the Head of Cards, Payment Solutions, E-Commerce Ecosystem, Merchant Ecosystem, and Consumer Finance, has resigned from his position, effective May 18.
* HUDCO: The company is in touch with Surat Integrated Transportation Development Corporation to develop the Surat Multi-Model Transportation Hub.
* Zydus Lifesciences: The pharmaceutical company has received the US FDA's final approval to market Dexamethasone tablets in the US, a drug used to treat a wide range of health conditions.
* Piramal Pharma: The company reported a 102.1% YoY increase in net profit at ₹101.3 crore for Q4FY24. The company's revenue from operations increased by 18% to ₹2,552.4 crore. The board recommended a final dividend of ₹0.11 per equity share for FY24.
* Tata Power: The company is discussing with group firms and various commercial and industrial customers to supply green energy solutions.
* Lupin: The pharmaceutical company re-launched Mirabegron ER tablets 25 mg in the US after the US Court lifted the temporary restraining order on Mirabegron ER tablets.
* Finolex Industries: The company reported a 1% YoY decline in net profit at ₹164.9 crore for Q4 of FY24. The company's revenue from operations increased by 8.3% to ₹1,235.4 crore. The board recommended a final dividend of ₹2.50 per fully paid-up equity share for FY24.
0 Comments